# Sublingual Misoprostol in Reduction of Caesarean Blood Loss

> **NCT05532215** · NA · UNKNOWN · sponsor: **OZORI EBIOGBO STANLEY** · enrollment: 152 (estimated)

## Conditions studied

- Post Partum Hemorrhage

## Interventions

- **DRUG:** Misoprostol
- **DRUG:** Oxytocin

## Key facts

- **NCT ID:** NCT05532215
- **Lead sponsor:** OZORI EBIOGBO STANLEY
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-14
- **Primary completion:** 2023-10-14
- **Final completion:** 2023-11-14
- **Target enrollment:** 152 (ESTIMATED)
- **Last updated:** 2023-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05532215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05532215, "Sublingual Misoprostol in Reduction of Caesarean Blood Loss". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05532215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*